Liver Transplantation as a New Standard of Care in Patients With Perihilar Cholangiocarcinoma? Results From an International Benchmark Study
Objective:
To define benchmark values for liver transplantation (LT) in patients with perihilar cholangiocarcinoma (PHC) enabling unbiased comparisons.
Background:
Transplantation for PHC is used with reluctance in many centers and even contraindicated in several countries. Although benchmark values for LT are available, there is a lack of specific data on LT performed for PHC.
Methods:
PHC patients considered for LT after Mayo-like protocol were analyzed in 17 reference centers in 2 continents over the recent 5-year period (2014–2018). The minimum follow-up was 1 year. Benchmark patients were defined as operated at high-volume centers (≥50 overall LT/year) after neoadjuvant chemoradiotherapy, with a tumor diameter
Source: Annals of Surgery - Category: Surgery Tags: ESA Paper Source Type: research
More News: Bile Duct Cancer | Cholangiocarcinoma | Liver | Liver Transplant | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study | Surgery | Transplants | Urology & Nephrology